Latest filing published 06 Aug 2026 for Axsome Therapeutics, Inc., €847k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Herriot Tabuteau in Axsome Therapeutics, Inc. The record holds 4 filings, for trades running from 9 June 2026 to 6 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 6 August 2026 with a transaction (€847k) in Axsome Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations